us-abfm MCQ (SBA): Dual-Pathway Inhibition in PAD

Instant feedback + full explanation. One question, done properly.

ModerateCardiologyDual-Pathway Inhibition in PADus-abfmus-abimus-usmle-step-2

A 65-year-old with PAD and no high bleeding risk is on aspirin 81 mg daily. He asks about intensifying therapy to prevent events. What should be recommended?

Educational content. Not a substitute for clinical judgement or local policy.

us-abfm MCQ: Dual-Pathway Inhibition in PAD — Answer & Explanation | i